Ho‐Ming Luk

1.4k total citations
67 papers, 471 citations indexed

About

Ho‐Ming Luk is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ho‐Ming Luk has authored 67 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Genetics, 30 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ho‐Ming Luk's work include Genomic variations and chromosomal abnormalities (13 papers), Genetic Syndromes and Imprinting (12 papers) and Genomics and Rare Diseases (11 papers). Ho‐Ming Luk is often cited by papers focused on Genomic variations and chromosomal abnormalities (13 papers), Genetic Syndromes and Imprinting (12 papers) and Genomics and Rare Diseases (11 papers). Ho‐Ming Luk collaborates with scholars based in China, Hong Kong and United States. Ho‐Ming Luk's co-authors include Ivan F. M. Lo, Brian Hon‐Yin Chung, Kelvin Y.K. Chan, Anita Sik Yau Kan, Kwong Wai Choy, Tak Yeung Leung, Wilson Chong, Chi Chiu Wang, Sidney Tam and Wai Lun Poon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BMC Public Health.

In The Last Decade

Ho‐Ming Luk

60 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho‐Ming Luk China 13 267 249 100 50 29 67 471
Alicia S. Martínez Argentina 10 256 1.0× 238 1.0× 75 0.8× 40 0.8× 12 0.4× 16 582
Luigina Spaccini Italy 13 159 0.6× 208 0.8× 104 1.0× 57 1.1× 19 0.7× 47 455
Mónica Rosello Spain 14 360 1.3× 295 1.2× 95 0.9× 21 0.4× 36 1.2× 41 535
Sandesh C. Sreenath Nagamani United States 6 218 0.8× 194 0.8× 70 0.7× 46 0.9× 14 0.5× 8 349
Erica H. Gerkes Netherlands 10 203 0.8× 221 0.9× 49 0.5× 37 0.7× 15 0.5× 14 386
Dinah Clark United States 15 250 0.9× 495 2.0× 57 0.6× 54 1.1× 32 1.1× 21 711
Luis Rohena United States 12 154 0.6× 192 0.8× 46 0.5× 39 0.8× 13 0.4× 27 383
Laëtitia Gouas France 13 150 0.6× 471 1.9× 75 0.8× 66 1.3× 38 1.3× 36 705
Ruolan Guo China 11 120 0.4× 158 0.6× 62 0.6× 31 0.6× 37 1.3× 41 332
Hiba Risheg United States 10 403 1.5× 374 1.5× 164 1.6× 31 0.6× 28 1.0× 13 640

Countries citing papers authored by Ho‐Ming Luk

Since Specialization
Citations

This map shows the geographic impact of Ho‐Ming Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho‐Ming Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho‐Ming Luk more than expected).

Fields of papers citing papers by Ho‐Ming Luk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho‐Ming Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho‐Ming Luk. The network helps show where Ho‐Ming Luk may publish in the future.

Co-authorship network of co-authors of Ho‐Ming Luk

This figure shows the co-authorship network connecting the top 25 collaborators of Ho‐Ming Luk. A scholar is included among the top collaborators of Ho‐Ming Luk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho‐Ming Luk. Ho‐Ming Luk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, G., et al.. (2025). RECQL4-related Rothmund-Thomson syndrome: A case series and literature review. Cancer Genetics. 292-293. 131–136.
2.
3.
4.
Luk, Ho‐Ming, et al.. (2024). Case report: Treatment response of NF-1-associated bladder ganglioneuroma to trametinib. Frontiers in Oncology. 14. 1433073–1433073.
5.
Luk, Ho‐Ming, et al.. (2024). Clinical and molecular characteristics of hemophilia A affected individuals and carriers: A 24 years experience from three centers. American Journal of Medical Genetics Part A. 194(9). e63657–e63657. 1 indexed citations
6.
Hai, Jo Jo, et al.. (2024). AP-482896-001 SUDDEN CARDIAC DEATH IN THE YOUNG AND FAMILIAL NEEDS. Heart Rhythm. 21(5). S46–S46. 1 indexed citations
7.
8.
Luk, Ho‐Ming, et al.. (2023). Fibrodysplasia ossificans progressiva in Hong Kong—A case report series. Frontiers in Pediatrics. 11. 1152731–1152731. 1 indexed citations
9.
Fung, Cheuk Wing, et al.. (2023). Public and Healthcare Provider Receptivity toward the Retention of Dried Blood Spot Cards and Their Usage for Extended Genetic Testing in Hong Kong. International Journal of Neonatal Screening. 9(3). 45–45. 2 indexed citations
10.
11.
Ou, Min, Amy Wing-Sze Leung, Ho‐Ming Luk, et al.. (2022). HKG: an open genetic variant database of 205 Hong Kong cantonese exomes. NAR Genomics and Bioinformatics. 4(1). lqac005–lqac005. 3 indexed citations
12.
Hui, Pui Wah, et al.. (2022). Prenatal presentation in two fetuses with features of Beckwith Wiedemann syndrome—An unexpected diagnosis of androgenetic chimera and its clinical implications. American Journal of Medical Genetics Part A. 188(5). 1562–1567. 2 indexed citations
13.
Cao, Ye, Ho‐Ming Luk, Yanyan Zhang, et al.. (2022). Investigation of Chromosomal Structural Abnormalities in Patients With Undiagnosed Neurodevelopmental Disorders. Frontiers in Genetics. 13. 803088–803088. 2 indexed citations
14.
Luk, Ho‐Ming, et al.. (2022). Genotype/phenotype correlation in 123 Chinese patients with Tuberous Sclerosis Complex. European Journal of Medical Genetics. 65(10). 104573–104573. 5 indexed citations
15.
Lau, Tze Kin, Anita Sik Yau Kan, Brian Hon‐Yin Chung, et al.. (2021). A Fetus with Congenital Microcephaly, Microphthalmia and Cataract Was Detected with Biallelic Variants in the OCLN Gene: A Case Report. Diagnostics. 11(9). 1576–1576.
16.
Luk, Ho‐Ming, Wujiang Gao, Christopher Chun Yu Mak, et al.. (2018). Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. Scientific Reports. 8(1). 2421–2421. 18 indexed citations
17.
Luk, Ho‐Ming. (2016). Familial Kagami–Ogata syndrome in Chinese. Clinical Dysmorphology. 26(2). 124–127. 7 indexed citations
18.
Luk, Ho‐Ming. (2016). A rare cause of temple syndrome. Clinical Dysmorphology. 26(1). 58–60. 2 indexed citations
19.
Luk, Ho‐Ming, et al.. (2013). Clinical and Molecular Characteristics of Cardio-facio-cutaneous Syndrome in Hong Kong Chinese. 18(1). 31–36. 1 indexed citations
20.
Luk, Ho‐Ming, et al.. (2012). Macrocephaly-capillary malformation. Clinical Dysmorphology. 21(2). 64–68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicia S. Martínez Breakdown of academic impact, for papers by Luigina Spaccini Breakdown of academic impact, for papers by Mónica Rosello Breakdown of academic impact, for papers by Sandesh C. Sreenath Nagamani Breakdown of academic impact, for papers by Erica H. Gerkes Breakdown of academic impact, for papers by Dinah Clark Breakdown of academic impact, for papers by Luis Rohena Breakdown of academic impact, for papers by Laëtitia Gouas Breakdown of academic impact, for papers by Ruolan Guo Breakdown of academic impact, for papers by Hiba Risheg
Rankless by CCL
2026